(Q34278933)

1 August 2017

1 reference

title

Dystrophin and mutations: one gene, several proteins, multiple phenotypes (English)

1 reference

1 August 2017

Francesco Muntoni

1

1 reference

PubMed ID

14636778

1 August 2017

Silvia Torelli

series ordinal

2

1 reference

PubMed ID

14636778

1 August 2017

Alessandra Ferlini

series ordinal

3

1 reference

1 August 2017

1 December 2003

1 reference

1 August 2017

1 reference

1 August 2017

2

1 reference

1 August 2017

731-740

1 reference

1 August 2017

12

1 reference

Dystrophin. The gene and its product

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Expression of the transcripts initiated in the 62nd intron of the dystrophin gene

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Transcriptional activation of the non-muscle, full-length dystrophin isoforms in Duchenne muscular dystrophy skeletal muscle.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Expression, regulation and localisation of dystrophin isoforms in human foetal skeletal and cardiac muscle.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Expression and localization of dystrophin in human cardiac Purkinje fibers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Human and murine dystrophin mRNA transcripts are differentially expressed during skeletal muscle, heart, and brain development

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Duchenne muscular dystrophy gene product is not identical in muscle and brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

The dystrophin lymphocyte promoter revisited: 4.5-megabase intron, or artifact?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Dystrophin and its isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Circular dystrophin RNAs consisting of exons that were skipped by alternative splicing

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Dystrophins and dystrobrevins

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Molecular basis of muscular dystrophies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Muscular dystrophies and the dystrophin-glycoprotein complex

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Molecular analysis of Duchenne muscular dystrophy: past, present, and future.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Dystrophin and related proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Dystrophin and dystrophin-related proteins: a review of protein and RNA studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Association of dystrophin and an integral membrane glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Molecular pathophysiology and targeted therapeutics for muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

The muscular dystrophies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

The limb-girdle muscular dystrophies-multiple genes, multiple mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Molecular pathophysiology of myofiber injury in deficiencies of the dystrophin-glycoprotein complex

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

The interaction of dystrophin with beta-dystroglycan is regulated by tyrosine phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Calmodulin-activated phosphorylation of dystrophin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Dystrophin expression in the human retina is required for normal function as defined by electroretinography

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

A novel dystrophin isoform is required for normal retinal electrophysiology.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Dp140: a novel 140 kDa CNS transcript from the dystrophin locus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

An alternative dystrophin transcript specific to peripheral nerve

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

A novel product of the Duchenne muscular dystrophy gene which greatly differs from the known isoforms in its structure and tissue distribution

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Cloning and characterization of alternatively spliced isoforms of Dp71

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Two hot spots of recombination in the DMD gene correlate with the deletion prone regions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Genomic organization of the human dystrophin gene across the major deletion hot spot and the 3' region

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Analysis of quantitative PCR for the diagnosis of deletion and duplication carriers in the dystrophin gene

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Accurate diagnosis of carriers of deletions and duplications in Duchenne/Becker muscular dystrophy by fluorescent dosage analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Comprehensive detection of genomic duplications and deletions in the DMD gene, by use of multiplex amplifiable probe hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Becker muscular dystrophy patient with a large intragenic dystrophin deletion: implications for functional minigenes and gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Very mild muscular dystrophy associated with the deletion of 46% of dystrophin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Characterization of deletions in the dystrophin gene giving mild phenotypes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Prognostic factors in mild dystrophinopathies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Familial X-linked myalgia and cramps: a nonprogressive myopathy associated with a deletion in the dystrophin gene

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Long mutant dystrophins and variable phenotypes: evasion of nonsense-mediated decay?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Deletions in the 5' region of dystrophin and resulting phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Predicted and observed sizes of dystrophin in some patients with gene deletions that disrupt the open reading frame

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Dystrophin expression in a Duchenne muscular dystrophy patient with a frame shift deletion

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Sequences of junction fragments in the deletion-prone region of the dystrophin gene.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

242 Breakpoints in the 200-kb deletion-prone P20 region of the DMD gene are widely spread

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

A transposon-like element in the deletion-prone region of the dystrophin gene

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Analysis of three deletion breakpoints in Xp21.1 and the further localization of RP3.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Non-homologous recombination between Alu and LINE-1 repeats caused a 430-kb deletion in the dystrophin gene: a novel source of genomic instability

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Analysis of 22 deletion breakpoints in dystrophin intron 49.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Investigating the mechanism of chromosomal deletion: characterization of 39 deletion breakpoints in introns 47 and 48 of the human dystrophin gene.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Relevance of sequence and structure elements for deletion events in the dystrophin gene major hot-spot

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Multiple exon skipping and RNA circularisation contribute to the severe phenotypic expression of exon 5 dystrophin deletion

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Dystrophin gene transcripts skipping the mdx mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Trans -acting factors may cause dystrophin splicing misregulation in BMD skeletal muscles

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Chimeric snRNA molecules carrying antisense sequences against the splice junctions of exon 51 of the dystrophin pre-mRNA induce exon skipping and restoration of a dystrophin synthesis in Delta 48-50 DMD cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Restoration of dystrophin expression in mdx muscle cells by chimeraplast-mediated exon skipping

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. II. Correlation of phenotype with genetic and protein abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Expression of human full-length and minidystrophin in transgenic mdx mice: implications for gene therapy of Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Gene therapy of muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Searching for the 1 in 2,400,000: a review of dystrophin gene point mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Point mutations in the dystrophin gene

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Protein truncation test: analysis of two novel point mutations at the carboxy-terminus of the human dystrophin gene associated with mental retardation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Point mutations in the dystrophin gene: evidence for frequent use of cryptic splice sites as a result of splicing defects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Protein truncation test (PTT) to rapidly screen the DMD gene for translation terminating mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Dystrophin point mutation screening using a multiplexed protein truncation test.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Dystrophin nonsense mutation induces different levels of exon 29 skipping and leads to variable phenotypes within one BMD family

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

DGGE analysis as a tool to identify point mutations, de novo mutations and carriers of the dystrophin gene

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Diagnosis of Duchenne dystrophy by enhanced detection of small mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Mutations in the dystrophin gene are associated with sporadic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Rapid direct sequence analysis of the dystrophin gene

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Detection of mutations in the dystrophin gene via automated DHPLC screening and direct sequencing

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Identification of a missense mutation, single base deletion and a polymorphism in the dystrophin exon 16

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Identification of point mutations in Turkish DMD/BMD families using multiplex-single stranded conformation analysis (SSCA)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

A cysteine 3340 substitution in the dystroglycan-binding domain of dystrophin associated with Duchenne muscular dystrophy, mental retardation and absence of the ERG b-wave

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

A dystrophin missense mutation showing persistence of dystrophin and dystrophin-associated proteins yet a severe phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

X-linked dilated cardiomyopathy and the dystrophin gene

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

A novel muscle-specific enhancer identified within the deletion overlap region of two XLDC patients lacking muscle exon 1 of the human dystrophin gene.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

A Point Mutation in the 5' Splice Site of the Dystrophin Gene First Intron Responsible for X-Linked Dilated Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Comprehensive mutation scanning of the dystrophin gene in patients with nonsyndromic X-linked dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Insertional mutation by transposable element, L1, in the DMD gene results in X-linked dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Association of nonsense mutation of dystrophin gene with disruption of sarcoglycan complex in X-linked dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Dilated cardiomyopathy and the dystrophin gene: an illustrated review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Brain function in Duchenne muscular dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Brain dystrophin, neurogenetics and mental retardation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Cognitive impairment in Duchenne muscular dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Deletion status and intellectual impairment in Duchenne muscular dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy, with special reference to mental ability

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

A deletion including the brain promoter of the Duchenne muscular dystrophy gene is not associated with mental retardation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Loss of Dp140 dystrophin isoform and intellectual impairment in Duchenne dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Are Dp71 and Dp140 brain dystrophin isoforms related to cognitive impairment in Duchenne muscular dystrophy?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Severe cognitive impairment in DMD: obvious clinical indication for Dp71 isoform point mutation screening

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Point mutations at the carboxy terminus of the human dystrophin gene: implications for an association with mental retardation in DMD patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Three novel RDS-peripherin mutations (689delT, 857del17, G208D) in Spanish families affected with autosomal dominant retinal degenerations. Mutations in brief no. 147. Online

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Novel nonsense mutation (C-->A nt 10512) in exon 72 of dystrophin gene leading to exon skipping in a patient with a mild dystrophinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

GABAergic terminals are required for postsynaptic clustering of dystrophin but not of GABA(A) receptors and gephyrin.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Facilitated CA1 hippocampal synaptic plasticity in dystrophin-deficient mice: role for GABAA receptors?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Short communication: altered synaptic clustering of GABAA receptors in mice lacking dystrophin (mdx mice)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Localization of dystrophin isoform Dp71 to the inner limiting membrane of the retina suggests a unique functional contribution of Dp71 in the retina.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Duchenne/Becker muscular dystrophy: correlation of phenotype by electroretinography with sites of dystrophin mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Effects of dystrophin isoforms on signal transduction through neural retina: genotype-phenotype analysis of duchenne muscular dystrophy mouse mutants.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Characterization of the ocular phenotype of Duchenne and Becker muscular dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Electroretinogram in Duchenne/Becker muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Negative-configuration electroretinogram in Oregon eye disease. Consistent phenotype in Xp21 deletion syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Differential distribution of the members of the dystrophin glycoprotein complex in mouse retina: effect of the mdx(3Cv) mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Targeted inactivation of dystrophin gene product Dp71: phenotypic impact in mouse retina

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Dp260 disrupted mice revealed prolonged implicit time of the b-wave in ERG and loss of accumulation of beta-dystroglycan in the outer plexiform layer of the retina.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Extra-muscle involvement in dystrophinopathies: an electroretinography and evoked potential study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

Dystrophin and the retina

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900585-4

7 January 2021

10.1016/S1474-4422(03)00585-4

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

14636778